Does the media prefer MBOT or KIDS?

In the previous week, OrthoPediatrics had 4 more articles in the media than Microbot Medical. MarketBeat recorded 7 mentions for OrthoPediatrics and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.62 beat OrthoPediatrics' score of 0.41 indicating that Microbot Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor SI or MBOT?

In the previous week, Shoulder Innovations and Shoulder Innovations both had 3 articles in the media. Microbot Medical's average media sentiment score of 0.62 beat Shoulder Innovations' score of 0.41 indicating that Microbot Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Microbot Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, CNXU or MBOT?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Microbot Medical N/A N/A -$13.14M -$0.26 N/A

Is CNXU or MBOT more profitable?

Conexeu Sciences' return on equity of 0.00% beat Microbot Medical's return on equity. Company Net Margins Return on Equity Return on Assets Conexeu Sciences N/A N/A N/A Microbot Medical N/A -21.84% -20.71%

Does the media refer more to CNXU or MBOT?

In the previous week, Conexeu Sciences had 15 more articles in the media than Microbot Medical. MarketBeat recorded 18 mentions for Conexeu Sciences and 3 mentions for Microbot Medical. Conexeu Sciences' average media sentiment score of 0.96 beat Microbot Medical's score of 0.62 indicating that Conexeu Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Microbot Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CV or MBOT?

In the previous week, Microbot Medical had 1 more articles in the media than CapsoVision. MarketBeat recorded 3 mentions for Microbot Medical and 2 mentions for CapsoVision. CapsoVision's average media sentiment score of 0.93 beat Microbot Medical's score of 0.62 indicating that CapsoVision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CapsoVision 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Microbot Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Microbot Medical (MBOT) Competitors

$1.96 +0.09 (+4.55%)

Closing price 06/30/2026 03:59 PM Eastern

Extended Trading

$1.96 0.00 (0.00%)

As of 04:16 AM Eastern

Compare

MBOT vs. KIDS, DCTH, SI, CNXU, and CV

Should you buy Microbot Medical stock or one of its competitors? MarketBeat compares Microbot Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Microbot Medical include OrthoPediatrics (KIDS), Delcath Systems (DCTH), Shoulder Innovations (SI), Conexeu Sciences (CNXU), and CapsoVision (CV). These companies are all part of the "medical equipment" industry.

How does Microbot Medical compare to OrthoPediatrics?

Microbot Medical (NASDAQ:MBOT) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Microbot Medical has a net margin of 0.00% compared to OrthoPediatrics' net margin of -16.31%. OrthoPediatrics' return on equity of -7.01% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

Microbot Medical has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
OrthoPediatrics	$236.35M	2.08	-$39.65M	-$1.68	N/A

Microbot Medical has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

In the previous week, OrthoPediatrics had 4 more articles in the media than Microbot Medical. MarketBeat recorded 7 mentions for OrthoPediatrics and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.62 beat OrthoPediatrics' score of 0.41 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Microbot Medical presently has a consensus price target of $6.63, suggesting a potential upside of 238.87%. OrthoPediatrics has a consensus price target of $24.44, suggesting a potential upside of 27.78%. Given Microbot Medical's higher possible upside, equities analysts clearly believe Microbot Medical is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

Microbot Medical and OrthoPediatrics tied by winning 8 of the 16 factors compared between the two stocks.

How does Microbot Medical compare to Delcath Systems?

Microbot Medical (NASDAQ:MBOT) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

In the previous week, Microbot Medical had 2 more articles in the media than Delcath Systems. MarketBeat recorded 3 mentions for Microbot Medical and 1 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.87 beat Microbot Medical's score of 0.62 indicating that Delcath Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
Microbot Medical	Positive
Delcath Systems	Very Positive

Microbot Medical has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

Microbot Medical currently has a consensus target price of $6.63, suggesting a potential upside of 238.87%. Delcath Systems has a consensus target price of $22.50, suggesting a potential upside of 78.71%. Given Microbot Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Microbot Medical is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43

Delcath Systems has a net margin of 0.62% compared to Microbot Medical's net margin of 0.00%. Delcath Systems' return on equity of 0.51% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
Delcath Systems	0.62%	0.51%	0.46%

Delcath Systems has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
Delcath Systems	$85.23M	5.10	$2.70M	$0.01	1,259.00

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Comparatively, 19.4% of Delcath Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Delcath Systems beats Microbot Medical on 11 of the 16 factors compared between the two stocks.

How does Microbot Medical compare to Shoulder Innovations?

Shoulder Innovations (NYSE:SI) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Shoulder Innovations presently has a consensus target price of $21.00, suggesting a potential upside of 3.39%. Microbot Medical has a consensus target price of $6.63, suggesting a potential upside of 238.87%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts clearly believe Microbot Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

Microbot Medical has a net margin of 0.00% compared to Shoulder Innovations' net margin of -81.78%. Microbot Medical's return on equity of -21.84% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-81.78%	-35.11%	-20.58%
Microbot Medical	N/A	-21.84%	-20.71%

In the previous week, Shoulder Innovations and Shoulder Innovations both had 3 articles in the media. Microbot Medical's average media sentiment score of 0.62 beat Shoulder Innovations' score of 0.41 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Microbot Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Microbot Medical has lower revenue, but higher earnings than Shoulder Innovations. Microbot Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	8.90	-$40.36M	-$166.96	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

16.3% of Microbot Medical shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by insiders. Comparatively, 4.7% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Microbot Medical beats Shoulder Innovations on 9 of the 14 factors compared between the two stocks.

How does Microbot Medical compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, media sentiment, analyst recommendations and risk.

Conexeu Sciences presently has a consensus price target of $20.00, suggesting a potential upside of 83.15%. Microbot Medical has a consensus price target of $6.63, suggesting a potential upside of 238.87%. Given Microbot Medical's higher probable upside, analysts plainly believe Microbot Medical is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

16.3% of Microbot Medical shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Conexeu Sciences' return on equity of 0.00% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Microbot Medical	N/A	-21.84%	-20.71%

In the previous week, Conexeu Sciences had 15 more articles in the media than Microbot Medical. MarketBeat recorded 18 mentions for Conexeu Sciences and 3 mentions for Microbot Medical. Conexeu Sciences' average media sentiment score of 0.96 beat Microbot Medical's score of 0.62 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Microbot Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Conexeu Sciences and Microbot Medical tied by winning 5 of the 10 factors compared between the two stocks.

How does Microbot Medical compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

16.3% of Microbot Medical shares are held by institutional investors. 2.3% of CapsoVision shares are held by insiders. Comparatively, 4.7% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Microbot Medical has a net margin of 0.00% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Microbot Medical	N/A	-21.84%	-20.71%

In the previous week, Microbot Medical had 1 more articles in the media than CapsoVision. MarketBeat recorded 3 mentions for Microbot Medical and 2 mentions for CapsoVision. CapsoVision's average media sentiment score of 0.93 beat Microbot Medical's score of 0.62 indicating that CapsoVision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CapsoVision	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Microbot Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CapsoVision currently has a consensus target price of $8.50, suggesting a potential upside of 12.14%. Microbot Medical has a consensus target price of $6.63, suggesting a potential upside of 238.87%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts plainly believe Microbot Medical is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

Microbot Medical has lower revenue, but higher earnings than CapsoVision. Microbot Medical is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	27.95	-$25.32M	-$2.34	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Summary

Microbot Medical beats CapsoVision on 10 of the 14 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MBOT vs. The Competition

Export

Metric	Microbot Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$125.60M	$7.31B	$7.07B	$12.45B
Dividend Yield	N/A	1.25%	2.66%	6.16%
P/E Ratio	-7.52	50.12	27.25	24.87
Price / Sales	N/A	80.49	543.53	102.84
Price / Cash	N/A	26.23	48.53	58.59
Price / Book	1.70	7.36	10.93	6.54
Net Income	-$13.14M	$159.19M	$3.57B	$336.70M
7 Day Performance	9.22%	-0.45%	2.31%	2.88%
1 Month Performance	-1.26%	-4.54%	1.39%	0.64%
1 Year Performance	-21.49%	4.53%	36.73%	31.34%

Microbot Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MBOT Microbot Medical	2.3769 of 5 stars	$1.96 +4.5%	$6.63 +238.9%	-22.4%	$125.60M	N/A	N/A	20	Gap Down
KIDS OrthoPediatrics	3.5939 of 5 stars	$18.16 -3.8%	$24.44 +34.6%	-10.9%	$484.68M	$243.30M	N/A	200
DCTH Delcath Systems	2.5333 of 5 stars	$11.51 -1.5%	$22.50 +95.5%	-7.4%	$403.56M	$85.23M	1,151.00	60	Positive News
SI Shoulder Innovations	2.1778 of 5 stars	$17.79 -4.1%	$21.00 +18.0%	N/A	$384.69M	$47.32M	N/A	61
CNXU Conexeu Sciences	4.6521 of 5 stars	$12.18 -8.3%	$20.00 +64.2%	N/A	$355.35M	N/A	N/A	4	Trending News Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MBOT) was last updated on 7/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Microbot Medical (MBOT) Competitors

MBOT vs. KIDS, DCTH, SI, CNXU, and CV

How does Microbot Medical compare to OrthoPediatrics?

Summary

How does Microbot Medical compare to Delcath Systems?

Summary

How does Microbot Medical compare to Shoulder Innovations?

Summary

How does Microbot Medical compare to Conexeu Sciences?

Summary

How does Microbot Medical compare to CapsoVision?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT vs. The Competition

Microbot Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Microbot Medical (MBOT) Competitors

MBOT vs. KIDS, DCTH, SI, CNXU, and CV

How does Microbot Medical compare to OrthoPediatrics?

Do insiders & institutionals believe in MBOT or KIDS?

Is MBOT or KIDS more profitable?

Which has higher earnings & valuation, MBOT or KIDS?

Which has more risk and volatility, MBOT or KIDS?

Does the media prefer MBOT or KIDS?

Do analysts recommend MBOT or KIDS?

Summary

How does Microbot Medical compare to Delcath Systems?

Does the media prefer MBOT or DCTH?

Which has more risk & volatility, MBOT or DCTH?

Do analysts recommend MBOT or DCTH?

Is MBOT or DCTH more profitable?

Which has preferable valuation & earnings, MBOT or DCTH?

Do insiders and institutionals believe in MBOT or DCTH?

Summary

How does Microbot Medical compare to Shoulder Innovations?

Do analysts rate SI or MBOT?

Is SI or MBOT more profitable?

Does the media favor SI or MBOT?

Which has higher earnings & valuation, SI or MBOT?

Do insiders and institutionals hold more shares of SI or MBOT?

Summary

How does Microbot Medical compare to Conexeu Sciences?

Do analysts prefer CNXU or MBOT?

Do institutionals and insiders hold more shares of CNXU or MBOT?

Which has better earnings & valuation, CNXU or MBOT?

Is CNXU or MBOT more profitable?

Does the media refer more to CNXU or MBOT?

Summary

How does Microbot Medical compare to CapsoVision?

Do insiders and institutionals believe in CV or MBOT?

Is CV or MBOT more profitable?

Does the media prefer CV or MBOT?

Do analysts prefer CV or MBOT?

Which has stronger earnings & valuation, CV or MBOT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT vs. The Competition

Microbot Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools